false. my comment was that they cannot afford to fund a phase III trial. That is a true statement.
someone else running a phase iii trial on their behalf in an indication that most are not confident in succeeding is not enough to raise the SP unless results surprise.
they themselves need to be able to fund a trial in kidney disease for this to be worth something.
false. my comment was that they cannot afford to fund a phase...
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
54.5¢ |
Change
0.015(2.83%) |
Mkt cap ! $299.6M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 54.5¢ | 52.0¢ | $905.8K | 1.698M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8606 | 53.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.5¢ | 72714 | 5 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| DXB (ASX) Chart |